| Description |
1 online resource (595 pages) |
| Contents |
Urgent Interventional Therapies; Copyright; Contents; List of Contributors; Foreword; Preface; List of Abbreviations; About the Companion Website; Part 1 Cardiac Interventions; Section I: Acute Coronary Syndrome; Chapter 1 Acute Coronary Syndrome: Guidelines and Definitions; Introduction; Definitions; Pathophysiology; Therapeutic strategies; Other considerations; References; Chapter 2 Cardiac Biomarkers in Acute Cardiac Care; Introduction; Markers of endothelial dysfunction; Biomarkers of vascular inflammation; Biomarkers of myocardial ischemia; Biomarkers of plaque destabilization |
|
Biomarkers of plaque ruptureBiomarkers of myocardial injury; Biomarkers of myocardial stretch or dysfunction; Summary; References; Chapter 3 Diagnosis of Vulnerable Plaque; Introduction; Coronary angiography; Intravascular ultrasound; Coronary angioscopy; Near-infared spectroscopy; Optical coherence tomography; Intravascular thermography; Interventional treatment of vulnerable plaques; Conclusion; Summary; References; Chapter 4 Management of Thrombotic Disorders: Heparin to Newer Anticoagulants; Introduction and overview; Low molecular weight heparins; Ultra-low molecular weight heparins |
|
Antithrombin agentsFactor Xa inhibitors; Generic antithrombotic drugs; Newer oral anticoagulants versus heparins; Some unanswered questions regarding the new oral anticoagulants; Summary; Future perspectives; References; Chapter 5 Newer Antiplatelet Agents for Interventional Indications; Introduction; Clopidogrel; Prasugrel; Ticagrelor; Conclusion; References; Chapter 6 Genetic Considerations of Antiplatelet Therapy; Introduction; General considerations; Specific genetic considerations; Therapeutic strategies; Practical recommendations; References |
|
Chapter 7 Anticoagulant Management of Heparin-Compromised PatientsIntroduction; Heparin; Anticoagulant alternatives to heparin; Summary; References; Chapter 8 Management of Bleeding in Urgent Interventions; Introduction; Incidence of bleeding; Risks associated with increased bleeding; Long-term outcomes; Mechanical and other contributors to bleeding; Measures to reduce the incidence of bleeding; Treatment of bleeding; New potential agents for the reversal of anticoagulation; References; Chapter 9 Role of Newer Anti-Xa and Anti-IIa Agents for Interventions; Introduction |
|
Percutaneous coronary interventionNew anti-IIa and anti-Xa agents; New anticoagulants for cardiac interventional procedures; Conclusion; Summary; References; Chapter 10 Treatment of NSTEMI Patients; Introduction; Presentation and diagnosis; Antiplatelet therapies; Anticoagulation strategies; Invasive versus medical therapy; Conclusion; References; Chapter 11 Treatment of Patients with STEMI; Introduction; Indication; Literature review; Invasive treatment center; Technique of primary PCI; Summary; References |
| Summary |
Illustrating the differences between urgent interventions and interventions performed to manage chronic conditions the authors present the chapters in a consistent template for ease of use covering; background, indications, evidence review, device description, procedural techniques, follow-up care, and complications. Shows the differences between interventions performed to manage chronic conditions and interventions that are truly urgentChapters follow a consistent structure from background through indications, evidence review, device description, procedural techniques to follow-up care and c |
| Notes |
Chapter 12 Mechanical Removal of Thrombus from Culprit Lesions: Current Devices and Future Developments |
|
Print version record |
| Subject |
Cardiovascular emergencies.
|
|
Critical care medicine.
|
|
Medical emergencies.
|
|
Critical Care
|
|
Emergencies
|
|
Cardiovascular emergencies.
|
|
Critical care medicine.
|
|
Medical emergencies.
|
|
Urgences en cardiologie.
|
|
Soins intensifs.
|
|
Urgences médicales.
|
| Form |
Electronic book
|
| Author |
Fareed, Jawed
|
|
Rosen, Robert T
|
|
Serruys, Patrick
|
| ISBN |
9781118504499 |
|
1118504496 |
|
